Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
BMJ (Clinical Research Ed.)|August 14, 2025
Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guidelineArnav Agarwal, Reem Mustafa, Veena Manja, et al.
Lancet (London, England)|December 13, 2021
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trialsQingyang Shi, Yang Wang, Qiukui Hao, et al.
Lancet (London, England)|April 6, 2024
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trialsQingyang Shi, Yang Wang, Qiukui Hao, et al.
BMJ Open|March 31, 2026
Investigating the impact of problematic evidence on clinical practice guidelines and associated patient outcomes (VITALITY Study II): protocolChang Xu, Luis Furuya Kanamori, Hong Cao, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|March 6, 2026
Cognitive Behavioral Interventions for Children and Adolescents With Overweight or Obesity: A Systematic Review and Component Network Meta-AnalysisXinran Xie, Yunhe Mao, Minghui Sun, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
Journal of Clinical Epidemiology|August 6, 2025
GRADE Concept Paper 9: Rationale and process for creating a GRADE OntologyPaul Whaley, Brian S Alper, Joanne Dehnbostel, et al.
BMJ Neurology Open|August 5, 2026
Clinicians' decisions about antibiotic treatment in advanced dementia: an international surveyJoão Pedro Lima, Lawrence Mbuagbaw, Manya Prasad, et al.
BMJ (Clinical Research Ed.)|July 8, 2026
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysisKailei Nong, Qingyang Shi, Xinran Xie, et al.
BMJ (Clinical Research Ed.)|May 4, 2022
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendationsQiukui Hao, Bert Aertgeerts, Gordon Guyatt, et al.
Pageof 16